Deep-Biotech: an umbrella that hosts our mission tracks
Explore new territories. R&D towards new applied research. Develop new products and outcomes to provide services to industries and end users.
Explore and develop new interdisciplinary R&D concepts, tied to applied use cases, covering market needs and gaps. Build new partnerships, consortiums, novel MVPs, products and services via Tracks 2, 3. Exploit outcomes in business development opportunities.
Basic and applied research development towards novel MVPs/PoC, products within state-of-the art science and technology in computational biology and deep-learning.
Outcomes: "DeNViS", Deep Neural Virtual Screening for drug discovery.
Services, R&D Consulting
Develop and deliver software engineering, production-level outcomes, publications, customised studies, tailor built solutions and consulting services to pharmaceutical, biotech-like industries.
More information soon.
Pipeline: Explore, R&D, Business Exploitation
Timeline and News
Mar 1, 2020
High-level motivation and brainstorming led to the initial drug discovery concept; after research we decided to focus on high-throughput virtual screening via structure-based protein-ligand affinity prediction.
May 1, 2020
R&D Self-funded Project
Form ML-Team; +new bio-engineer hiring; ongoing R&D work; production-level engineering scale up.
Jul 20, 2020
JEDI Grand Challenge submission
Successful fast screening of 1B molecules; submission of ranked compounds to the JEDI Grand challenge international effort against covid-19 related proteins.
Oct 1, 2020
- Virtual screening R&D cont'd
- Initiate single cell multi-omics tracks
- Develop research project proposals and networking with pharma/biotech companies.
Jan 5, 2021
- Bio-Explore concept and framework formation [Dec., 2021].
- New bioinformaticians/bio-explore team [Jan., 2021].
- Project kick-off [Feb., 2021].
Mar 1, 2021
Positive Outcomes, +Business
- JEDI positive feedback: deeplab is within 20-top finalists; molecules are to be screened in wet lab.
- New strategic health market and business lead position.
May 1, 2021
- Submit Virtual screening product (DeNViS) business proposals on open funding calls (EIT, Bio-Tools) [May, 2021].
- Technical report on Virtual Screening manuscript ready for publication.
- Single-cell multi-omics 2nd cycle proposals with pharma industry [May, 2021].
- Website goes live [Jun., 2021].